APT Medical Inc
SSE:688617
Intrinsic Value
APT Medical, Inc. engages in the research, development, production, and sale of electrophysiology, coronary access, and peripheral vascular intervention medical devices. [ Read More ]
The intrinsic value of one APT Medical Inc stock under the Base Case scenario is 386.91 CNY. Compared to the current market price of 503.68 CNY, APT Medical Inc is Overvalued by 23%.
Valuation Backtest
APT Medical Inc
Run backtest to discover the historical profit from buying and selling APT Medical Inc stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
APT Medical Inc
Current Assets | 1.8B |
Cash & Short-Term Investments | 1.3B |
Receivables | 50.5m |
Other Current Assets | 369.1m |
Non-Current Assets | 816.9m |
Long-Term Investments | 174.8m |
PP&E | 464.5m |
Intangibles | 131.1m |
Other Non-Current Assets | 46.5m |
Current Liabilities | 588.2m |
Accounts Payable | 42.7m |
Accrued Liabilities | 132.8m |
Short-Term Debt | 70m |
Other Current Liabilities | 342.7m |
Non-Current Liabilities | 77.7m |
Long-Term Debt | 8.6m |
Other Non-Current Liabilities | 69.1m |
Earnings Waterfall
APT Medical Inc
Revenue
|
1.7B
CNY
|
Cost of Revenue
|
-486.1m
CNY
|
Gross Profit
|
1.2B
CNY
|
Operating Expenses
|
-589.8m
CNY
|
Operating Income
|
574.3m
CNY
|
Other Expenses
|
-40.3m
CNY
|
Net Income
|
533.9m
CNY
|
Free Cash Flow Analysis
APT Medical Inc
Profitability Score
Profitability Due Diligence
APT Medical Inc's profitability score is 74/100. The higher the profitability score, the more profitable the company is.
Score
APT Medical Inc's profitability score is 74/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
APT Medical Inc's solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Score
APT Medical Inc's solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
APT Medical Inc
According to Wall Street analysts, the average 1-year price target for APT Medical Inc is 427.78 CNY with a low forecast of 405.6 CNY and a high forecast of 476.7 CNY.
Shareholder Return
Price
APT Medical Inc
Average Annual Return | 12.68% |
Standard Deviation of Annual Returns | 17.18% |
Max Drawdown | -68% |
Market Capitalization | 33.5B CNY |
Shares Outstanding | 67 556 900 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
APT Medical, Inc. engages in the research, development, production, and sale of electrophysiology, coronary access, and peripheral vascular intervention medical devices. The company is headquartered in Shenzhen, Guangdong and currently employs 1,511 full-time employees. The company went IPO on 2021-01-07. The firm's electrophysiological products include electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters and multichannel electrophysiological systems. Its coronary artery access products mainly include guide wires, micro catheters, balloons, contrast guide wires and catheters. The firm's peripheral vascular intervention products are mainly applied in peripheral vascular diseases. The firm is also engaged in related original equipment manufacturer (OEM) business. The firm distributes its products within domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one APT Medical Inc stock under the Base Case scenario is 386.91 CNY.
Compared to the current market price of 503.68 CNY, APT Medical Inc is Overvalued by 23%.